Posts by tag
CancerWorld
Bente Mikkelsen: “Success is Something We Build Together”
From the bedside to global reform, and why equity must be engineered, not hoped for “I think I chose medicine because it gave all the opportunities to address people, both at a national level, but also internationally. And it’s a…
Karen Knudsen: The Scientist Who Refused to Move Slowly
“I’m a scientist first and foremost. I don’t remember a time not thinking about being a scientist.” What Karen Knudsen, the CEO of Parker Institute for Cancer Immunotherapy, remembers clearly is the pull not toward prestige or power, but toward…
CancerWorld #113 (March 2026)
Scientific discovery drives oncology forward, but progress only truly begins when knowledge is turned into action. Every issue of CancerWorld explores the people, ideas, and systems shaping the future of oncology. Scientific breakthroughs remain essential, but their true value emerges…
“United by Unique” – Does it Really Make a Difference, or is it Just a Cliché?
“Nobody realizes that some people expend tremendous energy merely to be normal.”— Albert Camus People at the Centre of Care “United by Unique” is the World Cancer Day theme for 2025–2027. This year, the focus is on placing people at the…
Making Sense of a Decade of Progress in Advanced Breast Cancer: ABC8, Lisbon 2025
The 8th ABC International Consensus Conference (ABC8), Lisbon 2025 Over the past decade, the landscape of advanced breast cancer has changed more rapidly than at any time since systemic therapy became standard. New drug classes, more refined biomarkers, and increasingly…
Europe’s National Cancer Mission Hubs: From a Vision to Sustainable Infrastructures
European cancer policy has entered a decisive phase. After years of strategy-building, consultation, and pilot projects, the question facing policymakers is no longer whether Europe has the right ambitions, but whether it can turn those ambitions into sustainable systems that…
Rethinking Immunotherapy for Pancreatic Cancer: A Universal Approach
Chimeric antigen receptor natural killer T (CAR-NKT) cell therapy, a novel form of immunotherapy, is emerging as a promising ‘off-the-shelf’ treatment for patients with pancreatic cancer. In a study published in PNAS, November 21, 2025, U.S. investigators report that CAR-NKT cells…
The European Semester on Health: Why CPE is Calling for Action on Cancer Inequalities
Across the EU, cancer inequalities are stark along the entire care pathway – prevention, screening and early detection, diagnosis and treatment, and survivorship care. HPV vaccination rates remain far below the 90% target in most countries; colorectal cancer screening ranges…
“A Novel Path With Risks”
Arjun K. Ghosh on Building Cardio-Oncology From Scratch and Why the Goal Is Almost Never to Stop Cancer Treatment Professor Arjun K. Ghosh A cappuccino sits within reach as Professor Arjun K. Ghosh talks—a coffee that keeps pace with a…
“The Path Forward is Clear”
Interview with Olivér Várhelyi, EU Commissioner for Health and Animal Welfare Image Credits: European Union 2025 - Source: European Parliament Cancer remains one of Europe’s most significant public health challenges, with incidence rising and inequalities in prevention, diagnosis, and care…